Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors - A review
- Akira Sawaki
- , Kenji Yamao
Research output: Contribution to journal › Article › peer-review
25
Link opens in a new tab
Citations
(Scopus)